- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07301047
App-Assisted Swallowing Program After Oral Cancer Surgery (AASP)
This study aims to examine the effects of a swallowing care program combined with an exercise mobile application (App) on swallowing function, anxiety, and quality of life in patients with oral cancer after flap reconstruction surgery. The goal is to determine whether integrating App-based swallowing exercises into postoperative care can improve rehabilitation outcomes compared with conventional care alone.
A purposive sampling method will be used to recruit 72 participants from the surgical wards of a medical center in northern Taiwan. Eligible patients scheduled for oral cancer tumor resection and flap reconstruction will be identified through consultation with plastic surgeons. After screening and informed consent, participants will be assigned to a control group or an experimental group, with approximately 36 patients in each group.
The control group will receive routine ward education and standard postoperative nursing care, while the experimental group will receive the same care plus an additional intervention using a swallowing exercise App. The intervention will begin on postoperative day 7, guided by the researcher. Follow-up assessments will be conducted during outpatient visits at postoperative week 4 and week 12. To minimize potential interference between participants, data collection will be performed sequentially-first for the control group, followed by the experimental group.
Data will be collected through self-administered questionnaires or researcher-assisted interviews, including a demographic survey, the Postoperative Oral Dysfunction-10 (POD-10), the Functional Oral Intake Scale (FOIS), a Visual Analog Scale for Anxiety, and the EORTC QLQ-H&N35 questionnaire for quality of life. Each assessment will take approximately 20-30 minutes. Participants may withdraw from the study at any time without penalty.
Descriptive statistics will be used to summarize participant characteristics. The chi-square test and independent t-test will be used to examine group homogeneity. Paired t-tests will be applied to evaluate within-group changes in swallowing function, anxiety, and quality of life before and after the intervention. The results of this study are expected to provide empirical evidence on the effectiveness of App-assisted swallowing rehabilitation for patients with oral cancer following reconstructive surgery, supporting the development of innovative, technology-based postoperative care models.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study adopts a purposive sampling method and will be conducted in surgical wards of a medical center in northern Taiwan. A total of 72 participants will be recruited, with approximately 36 patients in the experimental group and 36 in the control group, based on the sample size estimation.
Participants will be identified by the researcher through consultation with plastic surgeons regarding patients scheduled for oral cancer tumor resection and flap reconstruction surgery. Eligible patients will be screened according to inclusion and exclusion criteria. One day before surgery, the researcher will explain the study purpose and procedures to each patient. Those who agree to participate will sign an informed consent form and complete the baseline questionnaires either by self-administration or interview.
After surgery, when patients return to the ward, the intervention will begin on postoperative day 7. Participants will be divided into two groups:
Control group: receives routine ward education and standard postoperative care. Experimental group: receives the same routine care plus an additional intervention using a swallowing exercise mobile application (App). The researcher will assist participants in downloading and using the App.
Follow-up assessments will be conducted at 4 weeks and 12 weeks after surgery during outpatient clinic visits. To prevent contamination between participants, data will be collected sequentially-first from the control group and then from the experimental group.
Data collection instruments include a demographic questionnaire, the Postoperative Oral Dysfunction-10 (POD-10), Functional Oral Intake Scale (FOIS), Visual Analog Scale for Anxiety, and EORTC QLQ-H&N35 for quality of life. Each interview or questionnaire session will take approximately 20-30 minutes. Participants may withdraw at any time during the data collection process without penalty.
Data analysis will be performed using descriptive statistics to summarize participant characteristics. Homogeneity between groups will be tested using chi-square and independent t-tests. Paired t-tests will be used to compare pre- and post-intervention differences within groups. The study aims to evaluate the effects of an App-based swallowing exercise intervention on swallowing function, anxiety, and quality of life among patients with oral cancer after flap reconstruction surgery.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: CHUAN WEN HSU, Master
- Phone Number: 886+033281200* 886+0975367585
- Email: f22877@cgmh.org.tw
Study Locations
-
-
Taoyuan City
-
Taoyuan District, Taoyuan City, Taiwan, 333
- Chang Gung Memorial Hospital, Linkou Branch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Willing to sign a written informed consent form
- Diagnosed with oral cancer
- Hospitalized for first-time oral cancer tumor resection and flap reconstruction surgery
- Aged 18 years or older
- Conscious and mentally clear
- Able to communicate in Mandarin or Taiwanese
Exclusion Criteria:
- Diagnosed by a physician with poor postoperative wound healing that prevents participation in oral rehabilitation exercises
- Unable to perform oral rehabilitation exercises within one week after surgery, as determined by a physician
Withdrawal Criteria:
-Participants who withdraw consent at any time during the study will be excluded from further participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Swallowing Care + Exercise App Intervention
Participants receive a swallowing care program combined with a mobile exercise App, starting on postoperative day 7.
The App provides guided swallowing exercises, reminders, and progress tracking.
Follow-up assessments at weeks 4 and 12.
|
Participants receive a swallowing care program combined with a mobile exercise App, starting on postoperative day 7.
The App provides guided swallowing exercises, reminders, and progress tracking.
Follow-up assessments at weeks 4 and 12.
|
|
Active Comparator: Routine Postoperative Care
Participants receive standard postoperative care and routine ward education without the App-based swallowing intervention.
Assessments at the same time points as the experimental group.
|
Participants receive standard postoperative care and routine ward education without the App-based swallowing intervention.
Assessments at the same time points as the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Oral Dysfunction-10 (POD-10) questionnaire
Time Frame: Beginning on postoperative day 7, and during outpatient visits at postoperative week 4 and week 12.
|
Swallowing-related oral dysfunction was assessed using the Postoperative Oral Dysfunction-10 (POD-10) questionnaire.
The POD-10 is a patient-reported outcome measure consisting of 10 items, with total scores ranging from 0 to 40, where higher scores indicate more severe oral dysfunction.
|
Beginning on postoperative day 7, and during outpatient visits at postoperative week 4 and week 12.
|
|
The Functional Oral Intake Scale (FOIS)
Time Frame: Beginning on postoperative day 7, and during outpatient visits at postoperative week 4 and week 12.
|
Functional swallowing ability was evaluated using the Functional Oral Intake Scale (FOIS), a 7-point ordinal scale ranging from Level 1 (nothing by mouth) to Level 7 (total oral diet with no restrictions), where higher scores represent better oral intake function.
|
Beginning on postoperative day 7, and during outpatient visits at postoperative week 4 and week 12.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anxiety
Time Frame: begin on postoperative day 7, during outpatient visits at postoperative week 4 and week 12.
|
Anxiety levels were assessed using the Visual Analog Scale for Anxiety (VAS-A).
The scale ranges from 0 to 10, where 0 indicates no anxiety and 10 indicates the highest level of anxiety, with higher scores reflecting greater anxiety severity.
|
begin on postoperative day 7, during outpatient visits at postoperative week 4 and week 12.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quality of Life Scores Measured by EORTC QLQ-H&N35 at 4 and 12 Weeks After Surgery
Time Frame: postoperative day 7, during outpatient visits at postoperative week 4 and week 12.
|
Quality of life was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck 35 (EORTC QLQ-H&N35).
The questionnaire comprises multiple head and neck cancer-specific symptom items, with scores linearly transformed to a 0-100 scale.
Higher scores indicate greater symptom burden and poorer quality of life.
|
postoperative day 7, during outpatient visits at postoperative week 4 and week 12.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Yean Hsiao Chiu, PHD, Taipei Medical University
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202501330B0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Study Data/Documents
-
No individual participant data (IPD) or supporting documents will be shared. Only aggregated study results may be published in journals or presented at conferences.
Information identifier: No individual participant dataInformation comments: No individual participant data (IPD) or supporting documents will be shared. Only aggregated study results may be published in journals or presented at conferences.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Cancer
-
Anil ChaturvediNational Taiwan University HospitalRecruitingOral Cancer | Oral Cancer Screening | Oral PrecancerTaiwan
-
Royal Surrey County Hospital NHS Foundation TrustCompleted
-
King's College LondonGuy's and St Thomas' NHS Foundation TrustNot yet recruitingOral Cancer | Dysplasia | Mouth Cancer | Oral Lesions | Oral Pre-cancerUnited Kingdom
-
Combined Military Hospital, PakistanNational University of Medical Sciences, PakistanCompletedOral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerPakistan
-
University of WashingtonBlaze Bioscience Inc.TerminatedStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
Centre Francois BaclesseTerminatedCancer | Cognitive Function | Compliance | Oral TherapiesFrance
-
University of Michigan Rogel Cancer CenterRecruitingStage III Lip and Oral Cavity Cancer AJCC v8 | Oral Cavity Squamous Cell Carcinoma | Stage I Lip and Oral Cavity Cancer AJCC v8 | Stage II Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8United States
-
National Cancer Institute (NCI)CompletedLip and Oral Cavity Cancer | Oropharyngeal Cancer | Tongue Cancer | Oral LeukoplakiaUnited States
-
Pai PangActive, not recruitingOral Cancer Patients After Selective Neck DissectionChina
-
Helsinki University Central HospitalKarolinska Institutet; University of HelsinkiCompletedPeriodontal Diseases | Biomarker in Early Diagnosis | Oropharyngeal Cancers | Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity CancerFinland
Clinical Trials on Swallowing Care + Exercise App
-
National Taiwan University HospitalCompletedNasopharyngeal Cancer | DysphagiaTaiwan
-
Icahn School of Medicine at Mount SinaiCompletedDysphagiaUnited States
-
Federal University of BahiaCompletedParkinson Disease | DysphagiaBrazil
-
University of MiamiCompletedHead and Neck Cancer | Oropharynx CancerUnited States
-
University of AlbertaAlberta Cancer FoundationCompletedHead and Neck Cancer | DysphagiaCanada
-
VA Office of Research and DevelopmentUniversity of Wisconsin, MadisonCompletedDeglutition Disorders | Cerebrovascular AccidentUnited States
-
National Taiwan University HospitalCompletedEndotracheal Intubation | Dysphagia | Intake Status | Swallowing StatusTaiwan
-
University of AarhusHammel Neurorehabilitation Centre and University Research ClinicCompleted
-
Zonguldak Bulent Ecevit UniversityCompletedDeglutition Disorders | Rehabilitation | Neurogenic DysphagiaTurkey
-
The Third Affiliated hospital of Zhejiang Chinese...RecruitingStroke | DysphagiaChina